Long-term outcome of the treatment of high-risk tenosynovial giant cell tumor/pigmented villonodular synovitis with radiotherapy and surgery

被引:77
作者
Griffin, Anthony M. [2 ]
Ferguson, Peter C. [2 ]
Catton, Charles N. [1 ]
Chung, Peter W. M. [1 ]
White, Lawrence M. [3 ]
Wunder, Jay S. [2 ]
Bell, Robert S.
O'Sullivan, Brian [1 ]
机构
[1] Univ Toronto, Dept Radiat Oncol, Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M5G 2M9, Canada
[2] Mt Sinai Hosp, Dept Orthoped Surg, Univ Musculoskeletal Oncol Unit, Toronto, ON M5G 1X5, Canada
[3] Mt Sinai Hosp, Dept Med Imaging, Toronto, ON M5G 1X5, Canada
关键词
tenosynovial giant cell tumor; pigmented villonodular synovitis; radiotherapy; benign disease; local recurrence; synovectomy; PARTIAL ARTHROSCOPIC SYNOVECTOMY; RADIATION-THERAPY; RHEUMATOID-ARTHRITIS; TENDON SHEATH; LARGE JOINTS; KNEE; DIFFUSE; TUMOR; Y-90; EXPRESSION;
D O I
10.1002/cncr.26529
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: The treatment of diffuse tenosynovial giant cell tumor (TGCT) requires extensive surgical resection of the hypertrophic synovium and multiple soft tissue masses yet still may result in high rates of local failure. The authors of this report examined their experience in treating patients with advanced/multiply recurrent TGCT with a combination of surgery and external-beam radiotherapy. METHODS: Fifty patients who were treated for TGCT with radiotherapy and surgery from 1972 to 2006 were identified. Patient demographics, radiotherapy treatment parameters, surgical treatment, and oncologic and functional outcomes were evaluated. All patients had pathologic review at presentation and required at least 1 year follow-up. RESULTS: Forty-nine patients had diffuse TGCT with both intra-articular and extra-articular disease (1 had malignant TGCT). Twenty-eight patients (56%) were referred after at least 1 local recurrence. Thirty patients (60%) underwent at least 2 operations before radiotherapy. The mean dose of radiation delivered was 39.8 gray. At a mean follow-up of 94 months (range, 19-330 months), 47 patients (94%) had not developed a recurrence or had stable disease/signal characteristics on serial cross-sectional imaging (for those patients who had gross residual disease at the time of radiotherapy). Two patients required subsequent total hip arthroplasty because of progressive osteoarthritis, and there were 4 cases of avascular necrosis (only 1 post-treatment). Forty-one patients had good/excellent function. CONCLUSIONS: For patients with extensive or multiple local relapses or when surgery alone would result in a large burden of residual disease or major functional loss, the addition of moderate-dose adjuvant radiotherapy provided excellent local control while maintaining good function with low treatment-related morbidity. Cancer 2012. (c) 2012 American Cancer Society.
引用
收藏
页码:4901 / 4909
页数:9
相关论文
共 44 条
[1]   DIFFUSE AND LOCALIZED TENOSYNOVIAL GIANT-CELL TUMOR AND PIGMENTED VILLONODULAR SYNOVITIS - A CLINICOPATHOLOGICAL AND FLOW CYTOMETRIC DNA ANALYSIS [J].
ABDULKARIM, FW ;
ELNAGGAR, AK ;
JOYCE, MJ ;
MAKLEY, JT ;
CARTER, JR .
HUMAN PATHOLOGY, 1992, 23 (07) :729-735
[2]   External beam radiotherapy as postoperative treatment of diffuse pigmented villonodular synovitis [J].
Berger, Bernhard ;
Ganswindt, Ute ;
Bamberg, Michael ;
Hehr, Thomas .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (04) :1130-1134
[3]   Malignant giant cell tumor of the tendon sheaths and joints (malignant pigmented villonodular synovitis) [J].
Bertoni, F ;
Unni, KK ;
Beabout, JW ;
Sim, FH .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (02) :153-163
[4]   Unacceptable complications following intra-articular injection of yttrium 90 in the ankle joint for diffuse pigmented villonodular synovitis [J].
Bickels, Jacob ;
Isaakov, Josephine ;
Kollender, Yehuda ;
Meller, Isaac .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2008, 90A (02) :326-328
[5]   Combined partial arthroscopic synovectomy and radiation therapy for diffuse pigmented villonodular synovitis of the knee [J].
Blanco, CER ;
Leon, HO ;
Guthrie, TB .
ARTHROSCOPY, 2001, 17 (05) :527-531
[6]   Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT) [J].
Blay, J. -Y. ;
El Sayadi, H. ;
Thiesse, P. ;
Garret, J. ;
Ray-Coquard, I. .
ANNALS OF ONCOLOGY, 2008, 19 (04) :821-U1
[7]   Extraarticular pigmented villonodular synovitis - A cause for failed knee arthroscopy [J].
Chin, KR ;
Brick, GW .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2002, (404) :330-338
[8]   Treatment of advanced primary and recurrent diffuse pigmented villonodular synovitis of the knee [J].
Chin, KR ;
Barr, SJ ;
Winalski, C ;
Zurakowski, D ;
Brick, GW .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2002, 84A (12) :2192-2202
[9]   Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides [J].
Cupp, John S. ;
Miller, Melinda A. ;
Montgomery, Kelli D. ;
Nielsen, Torsten O. ;
O'Connell, John X. ;
Huntsman, David ;
van de Rijn, Matt ;
Gilks, Cyril B. ;
West, Robert B. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (06) :970-976
[10]   Development of a measure of physical function for patients with bone and soft tissue sarcoma [J].
Davis, AM ;
Wright, JG ;
Williams, JI ;
Bombardier, C ;
Griffin, A ;
Bell, RS .
QUALITY OF LIFE RESEARCH, 1996, 5 (05) :508-516